# Study to Evaluate Efficacy and Safety in Males Subjects With Premature Ejaculation

> **NCT00983151** · PHASE3 · TERMINATED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 1050 (estimated)

## Conditions studied

- Premature Ejaculation

## Interventions

- **DRUG:** Tramadol Hydrochloride & Placebo

## Key facts

- **NCT ID:** NCT00983151
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 1050 (ESTIMATED)
- **Last updated:** 2012-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00983151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00983151, "Study to Evaluate Efficacy and Safety in Males Subjects With Premature Ejaculation". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00983151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*